J H Best
Overview
Explore the profile of J H Best including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bounthavong M, Tran J, Golshan S, Piland N, Morello C, Blickensderfer A, et al.
Diabetes Metab
. 2014 Jul;
40(4):284-91.
PMID: 25059703
Aim: This was a retrospective cohort study that evaluated the differences in glycated haemoglobin (HbA1c) and body mass index (BMI) in veterans with type 2 diabetes mellitus (T2DM), prescribed exenatide...
2.
Scott D, Boye K, Timlin L, Clark J, Best J
Diabetes Obes Metab
. 2012 Sep;
15(3):213-23.
PMID: 22958381
Aims: The glucagon-like peptide-1 receptor agonists (GLP-1 RAs) exenatide once weekly (ExQW) and liraglutide once daily (QD) are indicated to improve glycaemic control in patients with type 2 diabetes. Although...
3.
Best J, Lavillotti K, DeYoung M, Garrison L
Diabetes Obes Metab
. 2011 Nov;
14(5):387-98.
PMID: 22074017
The objective of this systematic review was to assess the published literature on the effectiveness of exenatide twice daily (exenatide) in clinical practice, specifically its effects on haemoglobin A1c (A1C),...
4.
Polonsky W, Fisher L, Hessler D, Bruhn D, Best J
Diabetes Obes Metab
. 2011 Jan;
13(2):144-9.
PMID: 21199266
Aim: to examine patient beliefs, preferences and concerns regarding a once-weekly (QW) glucose-lowering medication option. Methods: a total of 1516 adults with type 2 diabetes drawn from a national Chronic...
5.
Best J, Boye K, Rubin R, Cao D, Kim T, Peyrot M
Diabet Med
. 2009 Jul;
26(7):722-8.
PMID: 19573122
Aims: To assess treatment satisfaction and weight-related quality of life (QOL) in subjects with Type 2 diabetes treated with exenatide once weekly (QW) or twice daily (BID). Methods: In this...
6.
Best J, Eddy F, Codd G
Aquat Toxicol
. 2003 Jul;
64(4):419-26.
PMID: 12878412
Liver mass (hepatosomatic index, HSI) increased by approximately 18% and water content in the gut by approximately 13 ml kg(-1) in freshwater rainbow trout exposed for 24 h to intact...
7.
Best J, Pflugmacher S, Wiegand C, Eddy F, Metcalf J, Codd G
Aquat Toxicol
. 2002 Aug;
60(3-4):223-31.
PMID: 12200087
Cyanobacteria (blue-green algae) can produce a variety of toxins including hepatotoxins e.g. microcystins, and endotoxins such as lipopolysaccharides (LPS). The combined effects of such toxins on fish are little known....
8.
Best J, Veenstra D, Geppert J
Liver Transpl
. 2001 Oct;
7(10):858-62.
PMID: 11679983
Liver transplantation, a resource-intensive medical procedure, is under particular scrutiny in the current era of cost containment. There have been significant changes in treatment protocols over the past decade; however,...
9.
Veenstra D, Best J, Hornberger J, Sullivan S, Hricik D
Am J Kidney Dis
. 1999 Apr;
33(5):829-39.
PMID: 10213637
Corticosteroids are an essential component of most immunosuppressive regimens currently used in renal transplantation because of their efficacy in reducing acute rejection and improving graft survival. Steroids, however, are associated...
10.
Veenstra D, Best J, Hornberger J, Sullivan S, Hricik D
Transplant Proc
. 1999 Mar;
31(1-2):301-2.
PMID: 10083116
No abstract available.